Aliases & Classifications for Arthritis

MalaCards integrated aliases for Arthritis:

Name: Arthritis 38 12 29 52 41 3 42 14 69
Inflammatory Joint Disease 52 69
Inflammatory Disorder of Joint 12

Classifications:



External Ids:

Disease Ontology 12 DOID:848
MeSH 42 D001168
NCIt 47 C2883
UMLS 69 C0003864

Summaries for Arthritis

MedlinePlus : 41 if you feel pain and stiffness in your body or have trouble moving around, you might have arthritis. most kinds of arthritis cause pain and swelling in your joints. joints are places where two bones meet, such as your elbow or knee. over time, a swollen joint can become severely damaged. some kinds of arthritis can also cause problems in your organs, such as your eyes or skin. types of arthritis include osteoarthritis is the most common type of arthritis. it's often related to aging or to an injury. autoimmune arthritis happens when your body's immune system attacks healthy cells in your body by mistake. rheumatoid arthritis is the most common form of this kind of arthritis. juvenile arthritis is a type of arthritis that happens in children. infectious arthritis is an infection that has spread from another part of the body to the joint. psoriatic arthritis affects people with psoriasis. gout is a painful type of arthritis that happens when too much uric acid builds up in the body. it often starts in the big toe. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary : Arthritis, also known as inflammatory joint disease, is related to systemic lupus erythematosus and necrobiosis lipoidica, and has symptoms including arthralgia, back pain and metatarsalgia. An important gene associated with Arthritis is TNF (Tumor Necrosis Factor), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Rayos and Adalimumab have been mentioned in the context of this disorder. Affiliated tissues include bone, t cells and testes, and related phenotypes are Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression and homeostasis/metabolism

Disease Ontology : 12 A bone inflammation disease that involves a response to irritation or injury, characterized by joint pain, swelling, stiffness located in joint and/or redness located in skin over the joint.

CDC : 3 MMWR: Arthritis and Activity Limitation by Urban-Rural County Classification

Wikipedia : 72 Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include... more...

Related Diseases for Arthritis

Diseases in the Arthritis family:

Transient Arthritis

Diseases related to Arthritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1213)
id Related Disease Score Top Affiliating Genes
1 systemic lupus erythematosus 32.8 CCL2 IL17A IL6 LTA PTPN22 TNF
2 necrobiosis lipoidica 32.7 MMP3 MMP9 SAA1
3 spinal stenosis 32.3 CXCL8 IL6 MMP9 TNF
4 psoriasis susceptibility 1 32.3 IL17A MMP3 TNF TNFSF11
5 rheumatoid arthritis 32.2 CCL2 CSF1 CXCL8 IL17A IL1A IL1B
6 lung disease 31.8 IL17A MMP3 TNF
7 lymphoma 31.5 IL17A IL1B IL6 TNF
8 rheumatic myocarditis 31.3 IL6 MMP1 MMP13 TNF
9 influenza 31.3 IL1B MMP3 MMP9
10 primary biliary cirrhosis 31.1 IL1A IL6 LTA TNF
11 neuropathy 31.1 IL1A MMP9 TNF TNFSF11
12 myopathy 30.8 CXCL8 MMP1 MMP9 TNF
13 calciphylaxis 30.8 IL1B IL6 MMP9
14 toxoplasmosis 30.7 IL6 LTA TNF
15 calcinosis 30.7 CCL2 IL6 TNF
16 pneumoconiosis 30.6 CCL2 CXCL8 IL6
17 alopecia 30.6 CCL2 CXCL8 IL6 TNF
18 pulmonary tuberculosis 30.6 CCL2 CXCL8 TNF
19 common variable immunodeficiency 30.5 LTA MMP9
20 scabies 30.5 CCL2 CXCL8 IL1B IL6 TNF
21 pyelonephritis 30.5 CXCL8 IL1B TNF
22 allergic bronchopulmonary aspergillosis 30.4 CCL2 CXCL8 IL6
23 degenerative disc disease 30.4 IL1B IL6 LACC1 TNF
24 autoimmune hepatitis 30.4 CCL2 IL1B MMP3 MMP9 SAA1 TNF
25 pulmonary hypertension 30.4 IL1B MMP1 TNF
26 tracheal stenosis 30.4 IL17A IL6 TNF
27 aspartylglucosaminuria 30.4 IL1B IL6 LACC1 LTA TNF
28 churg-strauss syndrome 30.4 CXCL8 IL17A IL1B TNF
29 cytomegalovirus retinitis 30.4 CCL2 CXCL8
30 c1 inhibitor deficiency 30.4 IL17A IL6 TNF
31 pityriasis rosea 30.3 IL6 MMP9 TNF
32 asthma 30.3 CXCL8 IL17A IL1A IL1B IL6 MMP1
33 dysphagia 30.2 CXCL8 IL6 TNF
34 myocardial infarction 30.2 CCL2 IL1B IL6 LTA MMP1 MMP3
35 hypervitaminosis d 30.2 IL1B IL6 TNF
36 impotence 30.2 CSF1 IL1A TNFSF11
37 acral lentiginous melanoma 30.1 IL1B IL6 TNF
38 acute pancreatitis 30.1 CCL2 CXCL8 IL1B IL6 MIF MMP3
39 pulmonary embolism 30.1 CCL2 CXCL8 IL1B IL6 MMP9 TNF
40 choroiditis 30.1 CCL2 CXCL8 IL1B IL6 TNF
41 granuloma annulare 30.0 CCL2 CSF1 IL1B MIF
42 cutaneous leishmaniasis 30.0 IL6 TNF
43 reticulosarcoma 30.0 CSF1 CXCL8 IL1B IL6 TNF
44 legionellosis 29.9 CXCL8 IL1A IL1B IL6 LTA TNF
45 kaposi sarcoma 29.7 IL1A IL1B IL6 LACC1 LTA MIF
46 atherosclerosis 28.0 CCL2 CSF1 CXCL8 IL17A IL1A IL1B
47 rheumatoid arthritis, systemic juvenile 12.4
48 septic arthritis 12.4
49 psoriatic arthritis 12.3
50 reactive arthritis 12.3

Graphical network of the top 20 diseases related to Arthritis:



Diseases related to Arthritis

Symptoms & Phenotypes for Arthritis

UMLS symptoms related to Arthritis:


arthralgia, back pain, metatarsalgia, muscle cramp, sciatica, joint swelling, joint stiffness

GenomeRNAi Phenotypes related to Arthritis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression GR00224-A-2 8.8 IL1A MMP13 MMP9

MGI Mouse Phenotypes related to Arthritis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.31 CSF1 IL17A IL1A IL1B IL6 LTA
2 immune system MP:0005387 10.27 LTA MIF MMP1 MMP3 MMP9 PTPN22
3 hematopoietic system MP:0005397 10.25 CSF1 IL17A IL1A IL1B IL6 LTA
4 endocrine/exocrine gland MP:0005379 10.11 TNFAIP6 TNFRSF11A TNFSF11 CSF1 IL17A IL6
5 integument MP:0010771 9.97 CSF1 IL1A IL1B IL6 MMP13 MMP9
6 neoplasm MP:0002006 9.81 IL6 MIF MMP1 MMP9 TNF TNFRSF11A
7 limbs/digits/tail MP:0005371 9.8 CSF1 LTA MMP13 MMP9 TNF TNFRSF11A
8 respiratory system MP:0005388 9.65 CSF1 IL17A IL6 LTA MMP9 PTPN22
9 skeleton MP:0005390 9.36 MMP13 MMP3 MMP9 TNF TNFRSF11A TNFSF11

Drugs & Therapeutics for Arthritis

FDA approved drugs:

id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Rayos 17 PREDNISONE Horizon Pharma July of 2012

Drugs for Arthritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 964)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
2
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1959-05-2, 59-05-2 126941
3
Abatacept Approved Phase 4,Phase 3,Phase 2,Phase 1 332348-12-6 10237
4
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 185243-69-0
5
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
6
rituximab Approved Phase 4,Phase 2,Phase 3,Phase 1 174722-31-7 10201696
7
Hydroxychloroquine Approved Phase 4,Phase 3,Phase 2,Phase 1 118-42-3 3652
8
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 83-43-2 6741
9
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 16590-41-3 5360515
10
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-24-8 5755
11
Sulfasalazine Approved Phase 4,Phase 2,Phase 3,Phase 1 599-79-1 5353980 5359476
12
Leflunomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75706-12-6 3899
13
Diclofenac Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 15307-86-5 3033
14
Etoricoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 202409-33-4 123619
15
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1 428863-50-7
16
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2216-51-5 16666
17
Cimetidine Approved Phase 4,Phase 3,Phase 2 51481-61-9 2756
18
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-02-2 5743
19
Spironolactone Approved Phase 4,Phase 2 1952-01-7, 52-01-7 5833
20
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 169590-42-5 2662
21
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 161796-78-7, 119141-88-7 4594 9579578
22
Naproxen Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22204-53-1 1302 156391
23
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 9004-61-9 53477741 24759
24
Dimethyl fumarate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 624-49-7 5271565 637568
25
Zinc Approved Phase 4,Phase 3,Phase 2 7440-66-6 32051 23994
26
Polidocanol Approved Phase 4 9002-92-0
27
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
28
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
29
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 103-90-2 1983
30
Azathioprine Approved Phase 4,Phase 3,Phase 2 446-86-6 2265
31
Iron Approved Phase 4,Phase 1,Phase 2 7439-89-6 23925
32
Rivaroxaban Approved Phase 4,Phase 3 366789-02-8
33
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3,Phase 1 1197-18-8 5526
34
Tranylcypromine Approved Phase 4 155-09-9 441233
35
Ropivacaine Approved Phase 4,Phase 2,Phase 3 84057-95-4 71273 175805
36
Denosumab Approved Phase 4,Phase 2,Phase 1 615258-40-7
37
Hyoscyamine Approved Phase 4 101-31-5 64692
38
Milnacipran Approved Phase 4 92623-85-3 65833
39
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-41-2 439260
40
Everolimus Approved Phase 4,Phase 1,Phase 2 159351-69-6 6442177
41
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 22916-47-8 4189
42
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128794-94-5 5281078
43
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 24280-93-1 446541
44
Sirolimus Approved, Investigational Phase 4,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
45
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 104987-11-3 445643 439492
46
Calcium Carbonate Approved Phase 4,Phase 3,Phase 2 471-34-1
47
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
48
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3 51-43-4 5816
49
Ketorolac Approved Phase 4,Phase 2,Phase 3 74103-06-3, 66635-83-4 3826
50
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 57-27-2 5288826

Interventional clinical trials:

(show top 50) (show all 6510)

id Name Status NCT ID Phase Drugs
1 Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis Unknown status NCT00573651 Phase 4
2 Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis Unknown status NCT00291915 Phase 4 Adalimumab;Methotrexate
3 Hanyang University Medical Center Arthritis Network Unknown status NCT00418405 Phase 4
4 Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis Unknown status NCT01000441 Phase 4 infliximab, etanercept, adalimumab;abatacept, rituximab or tocilizumab
5 Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis Unknown status NCT02087696 Phase 4 Tocilizumab
6 Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis Unknown status NCT01939132 Phase 4 Open label H.P. Acthar Gel
7 Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI Unknown status NCT01893151 Phase 4 Iguratimod;Iguratimod placebo
8 Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis Unknown status NCT01301703 Phase 4
9 The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis Unknown status NCT00808496 Phase 4
10 Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) Unknown status NCT01303874 Phase 4 Etanercept (ETN);Placebo
11 Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis Unknown status NCT01287715 Phase 4 etanercept;etanercept
12 TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis Unknown status NCT00908089 Phase 4 Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab;Trexan+Salazopyrin+Oxiklorin+prednisolone + placebo
13 Remission Induction in Very Early Rheumatoid Arthritis Unknown status NCT00523692 Phase 4 Etanercept, methotrexate and depomedrone;depemedrone
14 Targeting Synovitis in Early Rheumatoid Arthritis Unknown status NCT00920478 Phase 4
15 Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis Unknown status NCT02275299 Phase 4 Iguratimod;Leflunomide;Methotrexate
16 Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis Unknown status NCT01002716 Phase 4
17 Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis Unknown status NCT02024334 Phase 4 Leflunomide
18 REstore Working Ability in RheumatoiD Arthritis Unknown status NCT01405326 Phase 4
19 Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) Unknown status NCT01067430 Phase 4 Etoricoxib;Diclofenac
20 Rheumatoid Arthritis Patients in Training Unknown status NCT00434200 Phase 4
21 Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker Unknown status NCT01072058 Phase 4 TNF blockers (infliximab, adalimumab, etanercept)
22 Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes Unknown status NCT02236481 Phase 4 Anakinra;TNF alpha inhibitors
23 Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. Unknown status NCT01835613 Phase 4
24 Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis Unknown status NCT00216177 Phase 4 Infliximab;Adalimumab
25 Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Unknown status NCT02132234 Phase 4 Etanercept;Adalimumab;Certolizumab;Infliximab
26 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Unknown status NCT01282528 Phase 4
27 Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine Unknown status NCT01980836 Phase 4
28 Bucillamine Study of Holding Remission After Infliximab Dose-off Unknown status NCT00716248 Phase 4 bucillamine;methotrexate
29 Very Early Versus Delayed Etanercept in Patients With RA Unknown status NCT02433184 Phase 4 Etanercept;Methotrexate;Sulfasalazine;Hydroxychloroquine;Etanercept;Methotrexate
30 Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate Unknown status NCT01270035 Phase 4 Adalimumab
31 Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis Unknown status NCT00180206 Phase 4
32 Gait Analysis of Ankle Arthroplasty and Arthrodesis Unknown status NCT00921076 Phase 4
33 Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis Unknown status NCT01223976 Phase 4
34 Bone Forming at Prosthetic Surfaces. Fingerprint2 Unknown status NCT01623687 Phase 4
35 Corticosteroids as Additive in Temporomandibular Joint (TMJ) Arthrocentesis Unknown status NCT01275014 Phase 4 Dexamethasone;Isotonic saline
36 The Long-term Evaluation of Glucosamine Sulphate Study Unknown status NCT00513422 Phase 4
37 The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy Unknown status NCT02539069 Phase 4
38 The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte) Unknown status NCT02539056 Phase 4
39 The Effect of Spironolactone on Pain in Older People With Osteoarthritis Unknown status NCT02046668 Phase 4 spironolactone
40 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
41 Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Unknown status NCT00815282 Phase 4 Human papilloma virus vaccine (cervarix)
42 A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis Unknown status NCT01985165 Phase 4 Imrecoxib
43 Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis Unknown status NCT02484508 Phase 4 Guli capsule;Kangguzengsheng capsule
44 Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis Unknown status NCT02355236 Phase 4 Naproxen/Esomeprazol 500/20mg;Celecoxib 200mg;Naxozol-Placebo;Comparator-Placebo
45 Comparison of Efficacy and Safety of Microfracture and Modified Microfracture Unknown status NCT02539030 Phase 4
46 Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline Injection Unknown status NCT02539095 Phase 4
47 Validation of a Stress Device for the Knee Unknown status NCT02444663 Phase 4
48 The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator Unknown status NCT00422643 Phase 4 Sodium hyaluronate (hyaluronic acid)
49 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Unknown status NCT01088165 Phase 4 Adalimumab treatment arm;Fumaric acid esters treatment group
50 An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst Unknown status NCT02154789 Phase 4 polidocanol

Search NIH Clinical Center for Arthritis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Arthritis cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Arthritis:
AlloStem
Embryonic/Adult Cultured Cells Related to Arthritis:
Adipose-derived mesenchymal stem cells combined with allograft bone (AlloStem PMIDs: 22500696

Cochrane evidence based reviews: arthritis

Genetic Tests for Arthritis

Genetic tests related to Arthritis:

id Genetic test Affiliating Genes
1 Arthritis 29

Anatomical Context for Arthritis

MalaCards organs/tissues related to Arthritis:

39
Bone, T Cells, Testes, Skin, Endothelial, Eye, B Cells

Publications for Arthritis

Articles related to Arthritis:

(show top 50) (show all 13214)
id Title Authors Year
1
Peripheral Bacterial Septic Arthritis: Review of Diagnosis and Management. ( 28926460 )
2017
2
Chest Pain Due to Pericardial Effusion as Initial Presenting Feature of Rheumatoid Arthritis: Case Report and Review of the Literature. ( 28868101 )
2017
3
Cutibacteriumacnes Septic Arthritis of the Nonoperated Knee: A Case Report. ( 28825032 )
2017
4
Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study. ( 28089968 )
2017
5
Proprotein convertase subtilisin/kexin type 6 promotes inA vitro proliferation, migration and inflammatory cytokine secretion of synovial fibroblasta89like cells from rheumatoid arthritis via nucleara89I_B, signal transducer and activator of transcription 3 and extracellular signal regulated 1/2 pathways. ( 28944919 )
2017
6
Bone fracture risk in patients with rheumatoid arthritis: A meta-analysis. ( 28885321 )
2017
7
Clinical significance of delta neutrophil index in the differential diagnosis between septic arthritis and acute gout attack within 24 hours after hospitalization. ( 28746185 )
2017
8
Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies. ( 28089967 )
2017
9
TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin. ( 28271077 )
2017
10
Cervical spine involvement risk factors in rheumatoid arthritis: a meta-analysis. ( 28524646 )
2017
11
Radiographic progression is less in psoriatic arthritis achieving a good response to treatment: data using newer composite indices of disease activity. ( 28834259 )
2017
12
Profiling arthritis pain with decision tree. ( 28949092 )
2017
13
Laryngeal stridor in rheumatoid arthritis. ( 28947548 )
2017
14
Induction and Differentiation of IL-10-Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients. ( 28087671 )
2017
15
TNFR1 and TNFR2 differentially mediate TNF-I+-induced inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes. ( 28150360 )
2017
16
YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis? ( 28384116 )
2017
17
Ulcerative necrobiosis lipoidica in the setting of anti-tumor necrosis factor-I+ and hydroxychloroquine treatment for rheumatoid arthritis. ( 28331899 )
2017
18
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry. ( 28089969 )
2017
19
Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report. ( 28487504 )
2017
20
Arthritis Progression on Serial MRIs Following Diagnosis of Medial Meniscal Posterior Horn Root Tear. ( 28950387 )
2017
21
Genetic association of aromatic hydrocarbon receptor and its repressor gene polymorphisms with risk of rheumatoid arthritis in Han Chinese populations. ( 28403070 )
2017
22
Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. ( 27457515 )
2017
23
Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis. ( 28089981 )
2017
24
Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship? ( 28052441 )
2017
25
Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis. ( 28083614 )
2017
26
Cervical facet joint septic arthritis: a real pain in the neck. ( 28775081 )
2017
27
Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity? ( 28488125 )
2017
28
Tailored Therapist-guided Internet-based Cognitive-behavioural Treatment for Psoriasis and Rheumatoid Arthritis: Two Case Reports. ( 28952654 )
2017
29
Level of agreement between three-dimensional volumetric ultrasound and real-time conventional ultrasound in the assessment of synovitis, tenosynovitis and erosions in rheumatoid arthritis patients. ( 27896420 )
2017
30
Anti-Gouty Arthritis and Antihyperuricemia Effects of Sunflower (Helianthus annuus) Head Extract in Gouty and Hyperuricemia Animal Models. ( 28929115 )
2017
31
Pristane induces autophagy in macrophages, promoting a STAT1-IRF1-TLR3 pathway and arthritis. ( 27940139 )
2017
32
Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation. ( 28516887 )
2017
33
Single strain versus multi-strain probiotics supplementation against rheumatoid arthritis. ( 28950432 )
2017
34
The coexistence of SAPHO syndrome and rheumatoid arthritis: A case report. ( 28072711 )
2017
35
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. ( 28081709 )
2017
36
Nephrocalcinosis in a patient with rheumatoid arthritis and secondary SjAPgren's syndrome. ( 28359765 )
2017
37
Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis. ( 28947312 )
2017
38
Osteomyelitis and arthritis caused by Mycobacterium intracellulare: an underestimated diagnosis. ( 28911365 )
2017
39
Pregnancy Outcomes in Patients with Psoriatic Arthritis. ( 28042130 )
2017
40
TH17 Cytokine Responses in Lyme Disease Correlate with Borreliaburgdorferi Antibodies During Early Infection in Patients with Erythema Migrans and with Autoantibodies Late in the Illness in Patients with Antibiotic-Refractory Lyme Arthritis. ( 28077518 )
2017
41
Rheumatoid arthritis: New model linking periodontitis and RA. ( 28053334 )
2017
42
Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy? ( 28375194 )
2017
43
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. ( 28529116 )
2017
44
Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation. ( 27165180 )
2017
45
Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies. ( 28154345 )
2017
46
Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. ( 28483767 )
2017
47
Impaired NK cell functionality and increased TNF-I+ production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis. ( 28213049 )
2017
48
The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis. ( 27775453 )
2017
49
Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review. ( 28499374 )
2017
50
A rare case of pulmonary toxoplasmosis in a patient with undifferentiated inflammatory arthritis on chronic methotrexate and corticosteroid therapy. ( 28835429 )
2017